Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2025-12-25 @ 8:07 PM
NCT ID: NCT04730635
Description: All-Cause Mortality (ACM) was reported for all randomized participants. Serious AEs and Other AEs were reported for the Safety Population: all randomized participants who received at least 1 dose of study medication.
Frequency Threshold: 0
Time Frame: Up to Week 10 (up to 70 days)
Study: NCT04730635
Study Brief: Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Donepezil Participants receive donepezil in doses up to 10 mg once daily (QD), orally in a scheduled titration for Days 1-56. The total treatment duration is 56 days. 0 None 1 29 16 29 View
Placebo Participants receive placebo QD, orally for Days 1-56. The total treatment duration is 56 Days. 0 None 0 15 4 15 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Presyncope SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 25.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 25.1 View
Nightmare SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 25.1 View
Micturition urgency SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 25.1 View
Pruritus SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 25.1 View
Pruritus allergic SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 25.1 View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA 25.1 View
Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 25.1 View
Vitreous floaters SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 25.1 View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.1 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.1 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 25.1 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA 25.1 View
Food allergy SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA 25.1 View
Otitis media SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.1 View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.1 View
Urinary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 25.1 View
Fall SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 25.1 View
Skin laceration SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 25.1 View
SARS-CoV-2 test positive SYSTEMATIC_ASSESSMENT Investigations MedDRA 25.1 View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 25.1 View
Muscle spasms SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 25.1 View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 25.1 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 25.1 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 25.1 View
Radiculopathy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 25.1 View
Abnormal dreams SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 25.1 View
Emotional distress SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 25.1 View
Hypnagogic hallucination SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 25.1 View